volume 138 pages 112527

Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis

Publication typeJournal Article
Publication date2024-09-01
scimago Q1
wos Q1
SJR1.239
CiteScore7.2
Impact factor4.7
ISSN15675769, 18781705
Abstract
Sepsis-associated acute kidney injury (SA-AKI) represents a frequent complication of in critically ill patients. The objective of this study is to illuminate the potential protective activity of Micheliolide (MCL) and its behind mechanism against SA-AKI.
Found 
Found 

Top-30

Journals

1
2
3
International Immunopharmacology
3 publications, 27.27%
Phytomedicine
2 publications, 18.18%
Frontiers in Immunology
1 publication, 9.09%
Journal of Inflammation Research
1 publication, 9.09%
Journal of Agricultural and Food Chemistry
1 publication, 9.09%
Psychopharmacology
1 publication, 9.09%
Cytokine and Growth Factor Reviews
1 publication, 9.09%
Drug Design, Development and Therapy
1 publication, 9.09%
1
2
3

Publishers

1
2
3
4
5
6
Elsevier
6 publications, 54.55%
Taylor & Francis
2 publications, 18.18%
Frontiers Media S.A.
1 publication, 9.09%
American Chemical Society (ACS)
1 publication, 9.09%
Springer Nature
1 publication, 9.09%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
11
Share
Cite this
GOST |
Cite this
GOST Copy
Lei X. et al. Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis // International Immunopharmacology. 2024. Vol. 138. p. 112527.
GOST all authors (up to 50) Copy
Lei X., Wang J., Zhang F., Tang X., He F., Cheng S., Zou F., Yan W. Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis // International Immunopharmacology. 2024. Vol. 138. p. 112527.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.intimp.2024.112527
UR - https://linkinghub.elsevier.com/retrieve/pii/S1567576924010488
TI - Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis
T2 - International Immunopharmacology
AU - Lei, Xianghong
AU - Wang, Jiyang
AU - Zhang, Fengxia
AU - Tang, Xianhu
AU - He, Fengxia
AU - Cheng, Shiqiang
AU - Zou, Fangqin
AU - Yan, Wenjun
PY - 2024
DA - 2024/09/01
PB - Elsevier
SP - 112527
VL - 138
PMID - 38950457
SN - 1567-5769
SN - 1878-1705
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Lei,
author = {Xianghong Lei and Jiyang Wang and Fengxia Zhang and Xianhu Tang and Fengxia He and Shiqiang Cheng and Fangqin Zou and Wenjun Yan},
title = {Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis},
journal = {International Immunopharmacology},
year = {2024},
volume = {138},
publisher = {Elsevier},
month = {sep},
url = {https://linkinghub.elsevier.com/retrieve/pii/S1567576924010488},
pages = {112527},
doi = {10.1016/j.intimp.2024.112527}
}